Search research articles
Contact Us
Filters
Showing results (151-160 of 189) with videos related to
Page
of 19
Sort By:
Neuromuscular Disorders : NMD
|
June 19, 2017
Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains
Elizabeth Harris, Umar Burki, Chiara Marini-Bettolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 20, 2013
Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study
Anu Goenka, Benedict D Michael, Elizabeth Ledger, et al.
Annals of Neurology
|
July 26, 2016
Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination
Yi Shiau Ng, Catherine Feeney, Andrew M Schaefer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 24, 2018
Mutations in XRCC1 cause cerebellar ataxia and peripheral neuropathy
Emer O'Connor, Jana Vandrovcova, Enrico Bugiardini, et al.
JAMA Neurology
|
November 25, 2014
Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28
Gráinne S Gorman, Gerald Pfeffer, Helen Griffin, et al.
Neurology
|
November 8, 2013
Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions
Charlotte L Alston, Andrew M Schaefer, Pravrutha Raman, et al.
BMJ Open Respiratory Research
|
November 2, 2019
Training opportunities in thoracic ultrasound for respiratory trainees: are current guidelines practical?
Andrew E Stanton, Matthew Evison, Mark Roberts, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2020
RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature
Rahul Phadke, Carola Hedberg-Oldfors, Renata S Scalco, et al.
Journal of Neurology
|
February 28, 2024
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Benedikt Schoser, Priya S Kishnani, Drago Bratkovic, et al.
Muscle & Nerve
|
May 9, 2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL
Hani Kushlaf, Jordi Díaz-Manera, Drago Bratkovic, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 189) with videos related to
Sort By:
Page
of 19
Neuromuscular Disorders : NMD
|
June 19, 2017
Complex phenotypes associated with STIM1 mutations in both coiled coil and EF-hand domains
Elizabeth Harris, Umar Burki, Chiara Marini-Bettolo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 20, 2013
Neurological manifestations of influenza infection in children and adults: results of a National British Surveillance Study
Anu Goenka, Benedict D Michael, Elizabeth Ledger, et al.
Annals of Neurology
|
July 26, 2016
Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination
Yi Shiau Ng, Catherine Feeney, Andrew M Schaefer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
February 24, 2018
Mutations in XRCC1 cause cerebellar ataxia and peripheral neuropathy
Emer O'Connor, Jana Vandrovcova, Enrico Bugiardini, et al.
JAMA Neurology
|
November 25, 2014
Clonal expansion of secondary mitochondrial DNA deletions associated with spinocerebellar ataxia type 28
Gráinne S Gorman, Gerald Pfeffer, Helen Griffin, et al.
Neurology
|
November 8, 2013
Late-onset respiratory failure due to TK2 mutations causing multiple mtDNA deletions
Charlotte L Alston, Andrew M Schaefer, Pravrutha Raman, et al.
BMJ Open Respiratory Research
|
November 2, 2019
Training opportunities in thoracic ultrasound for respiratory trainees: are current guidelines practical?
Andrew E Stanton, Matthew Evison, Mark Roberts, et al.
Journal of Inherited Metabolic Disease
|
March 19, 2020
RBCK1-related disease: A rare multisystem disorder with polyglucosan storage, auto-inflammation, recurrent infections, skeletal, and cardiac myopathy-Four additional patients and a review of the current literature
Rahul Phadke, Carola Hedberg-Oldfors, Renata S Scalco, et al.
Journal of Neurology
|
February 28, 2024
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease: a phase III open-label extension study (ATB200-07)
Benedikt Schoser, Priya S Kishnani, Drago Bratkovic, et al.
Muscle & Nerve
|
May 9, 2025
Switching Enzyme Replacement Therapy for Late-Onset Pompe Disease From Alglucosidase Alfa to Cipaglucosidase Alfa Plus Miglustat: Post Hoc Effect Size Analysis of PROPEL
Hani Kushlaf, Jordi Díaz-Manera, Drago Bratkovic, et al.
Page
of 19